I got barefoot at CES to test the Withings Body Scan 2 — and unlocked tons of longevity insights in just 90 seconds

I tried the new Withings Body Scan 2 at CES 2026 and was blown away by all the longevity-based wellness insights it generated ...
BioPharma Dive

FDA clears J&J’s drug-device combo for bladder cancer

Johnson & Johnson gained Inlexzo, formerly known as TAR-200, when it acquired privately held Taris Biomedical in 2019. The deal gave J&J a treatment it says could change way the “non-muscle invasive” ...

I let the Longevity Mirror scan my face at CES 2026 — and it predicted my long-term health outlook in just 30 seconds

I tested the viral ‘Longevity Mirror’ at CES 2026, allowing it to perform a 30-second selfie scan. The results: A set of ...
FiercePharma

Keytruda, Padcev keep winning streak with another patient survival benefit in bladder cancer

The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the treatment of bladder cancer. The PD-1/antibody-drug conjugate pairing ...